Stay updated on Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Expanded the study locations by adding numerous site locations across the US, Argentina, Australia, and Europe, broadening enrollment options. Removed the HHS Vulnerability Disclosure entry and several location groups.
    Difference
    4%
    Check dated 2025-12-23T21:57:39.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Publications section description updated to note that entries are automatically filled from PubMed and may not be about the study. Revision label updated from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T11:53:22.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed the prominent notice stating that information on the site may not be up to date due to a lapse in government funding. The notice previously advised users to check cc.nih.gov and opm.gov for operating status updates.
    Difference
    0.1%
    Check dated 2025-11-18T07:19:51.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The changes appear to be cosmetic, involving layout adjustments on the Study Details page, with no changes to core content such as eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:18:50.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Major update to page content: introduces a government funding/status notice and current operating status for NIH Clinical Center, and updates the version from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-06T05:54:10.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:11:06.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.